Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

JENNIFER CARVER Insider Profile

11 Followers

JENNIFER CARVER, Director at Revelation Biosciences, holds 44.77K shares in Revelation Biosciences (Ticker: REVB), holds 14.05K shares in La Jolla Pharma (Ticker: LJPC).

JENNIFER CARVER's Trading History

REVBRevelation Biosciences		Aug 18, 2026DirectorUninformative Buy―$180.42K
LJPCLa Jolla Pharma		Mar 04, 2019―Uninformative Buy1.12K$87.38K
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

JENNIFER CARVER insider profile FAQ

What is the percentage of profitable transactions made by JENNIFER CARVER?
The percentage of profitable transactions made by JENNIFER CARVER is 0%.
What is the average return per transaction made by JENNIFER CARVER?
The average return per transaction made by JENNIFER CARVER is -45.20%.
What stocks does JENNIFER CARVER hold?
JENNIFER CARVER holds: REVB, LJPC stocks.
What was JENNIFER CARVER's most profitable transaction?
JENNIFER CARVER’s most profitable transaction was an Informative Buy of LJPC stock on March 6, 2017. The return on the trade was -4.40%.
What is JENNIFER CARVER's role in Revelation Biosciences?
JENNIFER CARVER's role in Revelation Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.